MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $22,000 | -59.3% | 17,532 | 0.0% | 0.00% | -75.0% |
| Q1 2017 | $54,000 | -25.0% | 17,532 | 0.0% | 0.00% | -20.0% |
| Q4 2016 | $72,000 | -35.1% | 17,532 | 0.0% | 0.01% | -44.4% |
| Q3 2016 | $111,000 | +18.1% | 17,532 | 0.0% | 0.01% | +12.5% |
| Q2 2016 | $94,000 | -36.1% | 17,532 | 0.0% | 0.01% | -38.5% |
| Q1 2016 | $147,000 | +5.8% | 17,532 | 0.0% | 0.01% | +8.3% |
| Q4 2015 | $139,000 | -6.7% | 17,532 | 0.0% | 0.01% | -14.3% |
| Q3 2015 | $149,000 | -31.3% | 17,532 | 0.0% | 0.01% | -26.3% |
| Q2 2015 | $217,000 | +4.3% | 17,532 | 0.0% | 0.02% | 0.0% |
| Q1 2015 | $208,000 | +5.1% | 17,532 | 0.0% | 0.02% | 0.0% |
| Q4 2014 | $198,000 | +28.6% | 17,532 | 0.0% | 0.02% | +26.7% |
| Q3 2014 | $154,000 | +20.3% | 17,532 | 0.0% | 0.02% | +15.4% |
| Q2 2014 | $128,000 | +5.8% | 17,532 | -26.7% | 0.01% | +8.3% |
| Q1 2014 | $121,000 | -5.5% | 23,932 | 0.0% | 0.01% | -14.3% |
| Q4 2013 | $128,000 | – | 23,932 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lagoda Investment Management, L.P. | 2,211,880 | $17,474,000 | 4.63% |
| Parametrica Management Ltd | 21,228 | $168,000 | 1.11% |
| GARRISON BRADFORD & ASSOCIATES INC | 82,700 | $653,000 | 0.73% |
| Virtus ETF Advisers LLC | 33,570 | $265,000 | 0.73% |
| Opus Point Partners Management, LLC | 122,500 | $968,000 | 0.64% |
| NEXTHERA CAPITAL LP | 36,000 | $284,000 | 0.40% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 7,255,815 | $57,321,000 | 0.39% |
| Cannell & Co. | 1,051,178 | $7,751,000 | 0.25% |
| Tekla Capital Management LLC | 853,787 | $6,745,000 | 0.24% |
| STONERIDGE INVESTMENT PARTNERS LLC | 208,282 | $1,645,000 | 0.22% |